Consensus recommendations on sleeping problems in Phelan-McDermid syndrome

被引:3
作者
Casceres, A. San Jose [1 ,6 ,7 ]
Landlust, A. M. [2 ,3 ]
Carbin, J. M. [4 ]
Loth, E. [5 ]
机构
[1] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Ctr Invest Biomed Red Salud Mental CIBERSAM, Inst Salud Carlos 3,Dept Psiquiatria Nino & Adole, Madrid, Spain
[2] Lentis Psychiat Inst, Dept Youth Mental Hlth & Autism, Autism Team Northern Netherlands, Jonx, Groningen, Netherlands
[3] Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands
[4] Patient representat European Consensus PMS Grp, Groningen, Netherlands
[5] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Forens & Neurodev Sci, De Crespigny Pk, London, England
[6] Univ Gregorio Maran, Inst Psiquiatria, C-Ibiza 43, Madrid 28009, Spain
[7] Univ Gregorio Maranon, Salud Mental Hosp Gen, C-Ibiza 43, Madrid 28009, Spain
基金
欧盟地平线“2020”;
关键词
Phelan-McDermid syndrome; Sleep disorders; Sleep problems; Insomnia; Apnoea; 22Q13.3 DELETION SYNDROME; INTELLECTUAL DISABILITY; CHILDREN; DISORDERS; MANAGEMENT; DISTURBANCE; INSTRUMENT; CHILDHOOD; MELATONIN; ADULTS;
D O I
10.1016/j.ejmg.2023.104750
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Early onset sleep problems and disorders are very common in individuals with Phelan-McDermid Syndrome (PMS) with rates of up to 90%. These sleep problems and disorders cannot be taken lightly. Not only do they have a major impact on the health, behaviour, functioning and learning opportunities of affected individuals, they can also have detrimental effects on the well-being and resilience of parents and caregivers, ultimately affecting the physical health, mental health and well-being of the whole social system.In this review we aim to understand the types and frequencies of sleeping problems in PMS as the basis for recommendations on their management and treatment and to provide general guidelines for clinicians and practitioners. We conducted an in-depth literature search, summarised findings, and participated in a series of consensus meetings with other consortium members - experts on PMS and stakeholders - to agree on guidelines and recommendations. In parallel, a world-wide survey was created and distributed amongst parents to include their perspective.Our literature search found only four articles specifically focused on sleeping problems in PMS, although some other articles mentioned prevalence and associated factors. Country-specific prevalence rates ranged between 24% and 46%, whereas our parental survey reported 59%. The main problems reported involved difficulty falling asleep and numerous night awakenings, with being restless in sleep, night-time incontinence, and tooth grinding also commonly reported. Only a small number of individuals had undergone a sleep study monitored by a specialist. Bedtime resistance normally decreases with age, but sleep-onset delay, sleep anxiety, parasomnias, problems falling and remaining asleep remain throughout lifespan, with total sleep time improving during adulthood. However, this improvement was also accompanied by a substantial increase in parasomnias. Ultimately, an increase in sleep disorders in children correlates with increased sleep disorders and daytime sleepiness in parents/caregivers.No study to date has focused on the underlying causes of sleeping problems in PMS, but comorbid mental health conditions, somatic causes, or (poly)pharmacy have been proposed as triggers for sleeping disturbances. Currently there is no PMS-specific treatment for sleeping problems, and current recommendations are mostly based on individuals with intellectual disability and/or neurodevelopmental conditions.
引用
收藏
页数:9
相关论文
共 56 条
[1]   Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis [J].
Abdelgadir, Ibtihal Siddiq ;
Gordon, Morris A. ;
Akobeng, Anthony K. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2018, 103 (12) :1155-1162
[2]  
American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S
[3]   The Safety of Melatonin in Humans [J].
Andersen, Lars Peter Holst ;
Gogenur, Ismail ;
Rosenberg, Jacob ;
Reiter, Russel J. .
CLINICAL DRUG INVESTIGATION, 2016, 36 (03) :169-175
[4]   Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review [J].
Blackmer, Allison Beck ;
Feinstein, James A. .
PHARMACOTHERAPY, 2016, 36 (01) :84-98
[5]   Child sleep disorders: Associations with parental sleep duration and daytime sleepiness [J].
Boergers, Julie ;
Hart, Chantelle ;
Owens, Judith A. ;
Streisand, Randi ;
Spirito, Anthony .
JOURNAL OF FAMILY PSYCHOLOGY, 2007, 21 (01) :88-94
[6]   Sleep Disturbances in Individuals With Phelan-McDermid Syndrome: Correlation With Caregivers' Sleep Quality and Daytime Functioning [J].
Bro, Della ;
O'Hara, Ruth ;
Primeau, Michelle ;
Hanson-Kahn, Andrea ;
Hallmayer, Joachim ;
Bernstein, Jonathan A. .
SLEEP, 2017, 40 (02)
[7]   AGREE II: advancing guideline development, reporting and evaluation in health care [J].
Brouwers, Melissa C. ;
Kho, Michelle E. ;
Browman, George P. ;
Burgers, Jako S. ;
Cluzeau, Francoise ;
Feder, Gene ;
Fervers, Beatrice ;
Graham, Ian D. ;
Grimshaw, Jeremy ;
Hanna, Steven E. ;
Littlejohns, Peter ;
Makarski, Julie ;
Zitzelsberger, Louise .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (18) :E839-E842
[8]   The sleep disturbance scale for children (SDSC) construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence [J].
Bruni, O ;
Ottaviano, S ;
Guidetti, V ;
Romoli, M ;
Innocenzi, M ;
Cortesi, F ;
Giannotti, F .
JOURNAL OF SLEEP RESEARCH, 1996, 5 (04) :251-261
[9]   Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders [J].
Bruni, Oliviero ;
Angriman, Marco ;
Melegari, Maria Grazia ;
Ferri, Raffaele .
EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (18) :2257-2271
[10]  
de Cuba J., 2023, EUR J MED GENET